GRNJ
Fundstrat Granny Shots US Small & Mid Cap ETF
The Fundstrat Granny Shots US Small & Mid Cap ETF seeks to provide investors with long-term capital appreciation by investing in a diversified portfolio of U.S. small and mid-cap companies that are expected to benefit from innovative business models and strong earnings growth.
US
EQUITY
Active
MANAGEMENT STYLE
$ 552.1 M
ASSETS UNDER MGMT
75 bp
EXPENSES
Fund Basics
| Inception date | Nov 18, 2025 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| E.L.F. BEAUTY, INC. | 2.6 % |
| SANCHEZ ENERGY CORP | 2.5 % |
| HF SINCLAIR CORPORATION | 2.5 % |
| NATERA INC | 2.4 % |
| HALOZYME THERAPEUTICS INC | 2.2 % |
| UIPATH INC CLASS A | 2.1 % |
| CARPENTER TECHNOLOGY | 2.1 % |
| MONGODB, INC. CLASS A | 2.1 % |
| ZETA GLOBAL HOLDINGS CORP. CLASS A | 2.0 % |
| WATTS WATER TECHNOLOGIES-A | 2.0 % |
Constituent Breakdown
| Number of holdings | 61 |
| Herfindahl-Hirschman Index | 162 |
| Wgt avg mkt cap (mns) | $19,773 |
| Large cap (>$10bn) | 75.3% |
| Mid cap ($2-10bn) | 24.4% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 99.7% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 92.8 % |
 |
CANADA | 2.6 % |
 |
NETHERLANDS | 1.7 % |
 |
SWITZERLAND | 1.6 % |
 |
CAYMAN ISLANDS | 1.2 % |
Historical Performance
Standardized Performance (as of 07/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 10.4% | -- | -- | -- | -- | -- | -- | 16.0% |
| Dividend Yield | 0.0% | -- | -- | -- | -- | -- | -- | 0.0% |
| Total Returns | 10.4% | -- | -- | -- | -- | -- | -- | 16.0% | Ann. Volatility | 31.4% | -- | -- | -- | -- | -- | -- | 31.0% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.00 | 0% |
| MSCI EAFE | 0.00 | 0% |
| MSCI Emg Mkts | 0.00 | 0% |
Liquidity Measures
| Avg. volume (000) | 227 |
| ADV traded (mns) | $7 |
| Turnover | 1.3% |
| Avg. Bid/Ask (% of price) | 0.10% |
Technical Indicators
| 30d moving avg. (EMA) | $29.29 |
| Relative strength (RSI) | 45 |
| MACD/Signal | -0.66/-0.59 |
| Bollinger Bands (Upper/Lower) | $30.63/$27.34 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. GRNJ |
Expenses vs. GRNJ |
ALTAR Score™ vs. GRNJ |
|---|---|---|---|---|
| XMMO | Invesco S&P MidCap Momentum ETF | 25.0% | -41 bp | +1.8% |
| RFG | Invesco S&P Midcap 400 Pure Growth ETF | 23.0% | -40 bp | +3.1% |
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 21.0% | -60 bp | +2.3% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 21.0% | -58 bp | +2.3% |
| PAMC | Pacer Lunt MidCap Multi-Factor Alternator ETF | 20.6% | -15 bp | +5.2% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 20.5% | -65 bp | +2.3% |
| DBSC | Deepwater Beachfront Small Cap ETF | 16.9% | +10 bp | 0.0% |
| JSMD | Janus Henderson Small/Mid Cap Growth Alpha ETF | 16.6% | -45 bp | +2.5% |
| CSMD | Congress SMid Growth ETF | 16.4% | -6 bp | +1.6% |
| GRPM | Invesco S&P MidCap 400 GARP ETF | 16.3% | -40 bp | +4.8% |
Risk and Returns: GRNJ vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 8/9/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
2.4%
ALTAR SCORE™
8th
PERCENTILE
AVOID
ETFRC RATING
There are 1,402 funds in the US Equity category with an average
ALTAR Score™ of 5.2% and a standard deviation
of 2.0%. GRNJ's ALTAR Score™ is approximately -1.4 standard
deviations above the category average. This places GRNJ in the 8th percentile
among funds in the category.
Sell-Side Consensus
$34.08
PRICE TARGET
+10.8%
UPSIDE